Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
67 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Resolved | 2023-05-06 | 2023-06-09 | 191895 |
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Resolved | 2024-01-05 | 2024-01-12 | 215207 |
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Resolved | 2024-02-02 | 2024-03-15 | 218403 |
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Resolved | 2024-04-19 | 2024-05-24 | 225796 |
| APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-02-23 | 2024-03-22 | 220459 |
| APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-09-09 | 2020-11-02 | 123927 |
| APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-10-19 | 2019-05-03 | 64934 |
| APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-03-27 | 2019-05-03 | 79577 |
| APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-12-18 | 2018-07-03 | 33576 |
| APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-12-24 | 2022-04-14 | 151886 |
| APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-11-06 | 2024-02-09 | 209342 |
| APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-12-01 | 2024-02-09 | 212365 |
| APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-06-06 | 2024-10-18 | 229776 |
| APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-08-01 | 2025-01-03 | 234271 |
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-07-05 | 2024-11-01 | 232335 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-07-18 | 2024-11-01 | 233325 |
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-07-18 | 2024-11-22 | 233346 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-07-18 | 2024-11-01 | 233358 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-08-22 | 2024-11-01 | 235692 |
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-10-10 | 2024-11-01 | 239825 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |